Significant Shortages of Baby Formula Reported in the United States

FRIDAY, April 8, 2022 (HealthDay News) -- Supply chain problems are causing significant shortages of baby formula in the United States, and some retailers are now limiting how much people can buy at one time.
About three-quarters of U.S. babies receive formula within their first six months, but it is getting more difficult to find. About 29 percent of the top-selling baby formula products were out of stock at more than 11,000 monitored stores as of the week of March 13 compared with 11 percent in November, according to an analysis by Datasembly, CBS News reported.
"This is a shocking number that you don't see for other categories," Ben Reich, CEO of Datasembly, told CBS MoneyWatch. "We've been tracking it over time and it's going up dramatically. We see this category is being affected by economic conditions more dramatically than others."
In 24 U.S. states, 30 percent of formula was out of stock as of mid-March, but other states had even more severe shortages, according to Datasembly. Rates were 54 percent in Minnesota and at least 40 percent in Connecticut, Hawaii, Iowa, Louisiana, Maryland, North and South Dakota, Rhode Island, and Texas, CBS News reported.
During the first seven months of 2021, between 2 and 8 percent of baby formula products were out of stock. The supply chain problems affecting the supply of baby formula include difficulties getting key ingredients, worker shortages, and packaging issues, according to CBS News. In addition, there was a major recall of baby formula earlier this year.
Manufacturers are boosting production to meet the demand for baby formula, according to a recent statement posted on the Infant Nutrition Council of America website. The council also advised parents to keep a 10-day to two-week supply of formula at home but urged them not to stockpile it, CBS News reported.
Related Posts
Januvia, un medicamento común para la diabetes, podría contener vestigios de un cancerígeno, señala la FDA
VIERNES, 12 de agosto de 2022 (HealthDay News) -- Januvia, un popular fármaco...
U.S. COVID Vaccination Rates Climb in August
WEDNESDAY, Sept. 1, 2021 (HealthDay News) -- Nearly 14 million Americans got...
Un estudio muestra que la mayoría de los trabajadores de salud renuentes a vacunarse cambian de opinión
VIERNES, 4 de febrero de 2022 (HealthDay News) -- La mayoría de los trabajadores...
Los síntomas de COVID raras veces repuntan tras el tratamiento con Paxlovid, según un estudio
MARTES, 14 de junio de 2022 (HealthDay News) -- A pesar de las preocupaciones de...
